|
|
|
|
|
|
PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups
Magdalena Cizkova, Aurelie Susini, Sophie Vacher, Geraldine Cizeron-Clairac, Catherine Andrieu, Keltouma Driouch, Emmanuelle Fourme, Rosette Lidereau, Ivan Bieche Breast Cancer Research 2012, 14:R28 (13 February 2012)
Abstract | Provisional PDF
|
|
|
|
The growth response to androgen receptor signaling in ERalpha negative human breast cells is dependent on p21 and mediated by MAP kinase activation
Joe P Garay, Bedri Karakas, Abde M Abukhdeir, David P Cosgrove, John P Gustin, Michaela J Higgins, Hiroyuki Konishi, Yuko Konishi, Josh Lauring, Morassa Mohseni, Grace M Wang, Danijela Jelovac, Ashani Weeraratna, Cheryl A Sherman Baust, Patrice J Morin, Antoun Toubaji, Alan Meeker, Angelo M De Marzo, Gloria Lewis, Andrea Subhawong, Pedram Argani, Ben H Park Breast Cancer Research 2012, 14:R27 (9 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity
Anders Sundqvist, Peter ten Dijke, Hans van Dam Breast Cancer Research 2012, 14:204 (8 February 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
The role and function of cadherins in the mammary gland
Jennifer L Andrews, Alvin C Kim, Julie R Hens Breast Cancer Research 2011, 14:203 (8 February 2012)
Abstract | Full text | PDF
|
|
|
|
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Ginette Serrero, Douglas M Hawkins, Binbin Yue, Olga Ioffe, Pablo Bejarano, Jeffrey T Phillips, Jonathan F Head, Robert L Elliott, Katherine R Tkaczuk, Andrew K Godwin, JoEllen Weaver, Wes E Kim Breast Cancer Research 2012, 14:R26 (8 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Initiating breast cancer by PIK3CA mutation
Todd W Miller Breast Cancer Research 2012, 14:301 (7 February 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
Hatef Darabi, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, Keith Humphreys Breast Cancer Research 2012, 14:R25 (7 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Germline DNA copy number variation in familial and early-onset breast cancer
Ana C V Krepischi, Maria Isabel W Achatz, Erika M M Santos, Silvia S Costa, Bianca C G Lisboa, Helena Brentani, Tiago M Santos, Amanda Goncalves, Amanda F Nobrega, Peter L Pearson, Angela M Vianna-Morgante, Dirce M Carraro, Ricardo R Brentani, Carla Rosenberg Breast Cancer Research 2012, 14:R24 (7 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Contribution of CXCL12 secretion to invasion of breast cancer cells
Pamela J Boimel, Tatiana Smirnova, Zhen Ni Zhou, Jeffrey Wyckoff, Hae In Park, Salvatore J Coniglio, Purvi Patel, Bin-Zhi Qian, E RICHARD Stanley, Anne R Bresnick, Dianne Cox, Jeffrey W Pollard, William J Muller, John Condeelis, Jeffrey E Segall Breast Cancer Research 2012, 14:R23 (7 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumour-initiating cells
Kaiji Hu, Jennifer Law, Abbas Fotovati, Sandra E Dunn Breast Cancer Research 2012, 14:R22 (6 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study
Gitte V Sorensen, Deirdre P Cronin-Fenton, Henrik T Sorensen, Sinna P Ulrichsen, Lars Pedersen, Timothy L Lash Breast Cancer Research 2012, 14:R21 (3 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
José Pérez-García, Javier Cortés Breast Cancer Research 2012, 14:104 (31 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system
Yu Sun, Leahana M Rowehl, Liqun Huang, Gerardo G Machenzie, Kvetoslava Vrankova, Despina Komninou, Basil Rigas Breast Cancer Research 2012, 14:R20 (31 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women
Wen Yee Chay, Whee Sze Ong, Puay-Hoon Tan, Nicholas QJ Leo, Gay Hui Ho, Chia Siong Wong, Kee Seng Chia, Khuan Yew Chow, Min-han Tan, Peter CS Ang Breast Cancer Research 2012, 14:R19 (30 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis
Oriana E Hawkins, Ann Richmond Breast Cancer Research 2012, 14:103 (26 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Do fatty breasts increase or decrease breast cancer risk?
John A Shepherd, Karla Kerlikowske Breast Cancer Research 2012, 14:102 (25 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers
Desheng Weng, Jeffrey H Penzner, Baizheng Song, Shigeo Koido, Stuart K. Calderwood, Jianlin Gong Breast Cancer Research 2012, 14:R18 (25 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Breast cancer risk assessment with five independent genetic variants and two risk factors in chinese women
Juncheng Dai, Zhibin Hu, Yue Jiang, Hao Shen, Jing Dong, Hongxia Ma, Hongbing Shen Breast Cancer Research 2012, 14:R17 (23 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
STAT1-deficient mice spontaneously develop estrogen receptor alpha-positive luminal mammary carcinomas
Szeman R Chan, William Vermi, Jingqin Luo, Laura Lucini, Charles Rickert, Amy M Fowler, Silvia Lonardi, Cora Arthur, Larry JT Young, David E Levy, Michael J Welch, Robert D Cardiff, Robert D Schreiber Breast Cancer Research 2012, 14:R16 (20 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer, Oliver Hoffmann, Diethelm Wallwiener, Rainer Kimmig, Tanja Fehm Breast Cancer Research 2012, 14:R15 (20 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Understanding the mechanisms of aromatase inhibitor resistance
William R Miller, Alexey A Larionov Breast Cancer Research 2012, 14:201 (19 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave, Vivek Mittal, Nicholas M Tan, Jenny C Chang Breast Cancer Research 2011, 14:202 (19 January 2012)
Abstract | Full text | PDF
|
|
|
|
MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7
Seok-Jun Kim, Ji-Young Shin, Kang-Duck Lee, Young-Ki Bae, Ki Sung, Seok Nam, Kyung-Hee Chun Breast Cancer Research 2012, 14:R14 (18 January 2012)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
MicroRNA let-7a binds directly to the 3'UTR of C-C chemokine receptor type 7 (CCR7), blocking its protein expression and suppressing migration and invasion of breast cancer cells.
|
|
|
|
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE Trial Bone Sub-study
Nigel J Bundred, Peter Kenemans, Cheng Har Yip, Matthias W Beckmann, Jean-Michel Foidart, Piero Sismondi, Bo von Schoultz, Rena Vassilopoulou-Sellin, Rachid El Galta, Eugenie Van Lieshout, Mirjam Mol-Arts, Juan Planellas, Ernst Kubista Breast Cancer Research 2012, 14:R13 (17 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
Rosamaria Lappano, Maria Santolla, Marco Pupo, Maria Sinicropi, Anna Caruso, Camillo Rosano, Marcello Maggiolini Breast Cancer Research 2012, 14:R12 (17 January 2012)
Abstract | Provisional PDF
| PubMed
|
